KF Docherty, PS Jhund, SE Inzucchi, L Køber… - European Heart …, 2020 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Aims</jats: title>< jats: p> In the
DAPA-HF trial, the SGLT2 inhibitor dapagliflozin reduced the risk of worsening heart failure …